70e3556ce8e84edc77a27047f877fc2b-q4aabxl6s3eubvvh25l1w6q5ap52ggwuu2hlnt4914

Recce Pharmaceuticals Ltd (ASX:RCE, FSE: R9Q) is developing a New Class of Synthetic Anti-Infectives designed to address the urgent global health threat of antibiotic-resistant superbugs.